Momenta Pharmaceuticals, Inc. Letterhead]Momenta Pharmaceuticals Inc • November 14th, 2005 • Biological products, (no disgnostic substances)
Reference is made to the Consulting Agreement effective dated September 18, 2002 between Momenta Pharmaceuticals, Inc. (formerly Mimeon, Inc.) (“Company”) and you (“Consultant”), as exended and amended by the renewal agreements dated September 29, 2003 and October 4, 2004 (collectively, the “Agreement”). Capitalized terms used herein and not otherwise defined shall have the meanings given such terms in the Agreement. The parties hereby amend the Agreement as follows:
Momenta Pharmaceuticals, Inc. Letterhead]Momenta Pharmaceuticals Inc • November 14th, 2005 • Biological products, (no disgnostic substances)
Reference is made to the Industry Consulting Agreement effective as of October 4, 2004 (the “Agreement”) between Momenta Pharmaceuticals, Inc. (“Company”) and you (“Consultant”). Capitalized terms used herein and not otherwise defined shall have the meanings given such terms in the Agreement. The parties hereby amend the Agreement as follows:
FIRST AMENDMENT TO SUBLEASEMomenta Pharmaceuticals Inc • November 14th, 2005 • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO SUBLEASE (“Amendment”) is entered into as of this 7th day of September, 2005 by and between Vertex Pharmaceuticals Incorporated (“Sublandlord”) and Momenta Pharmaceuticals, Inc. (“Subtenant”).
